A trimeric structural domain of the HIV-1 transmembrane glycoprotein
- PMID: 8846219
- DOI: 10.1038/nsb1295-1075
A trimeric structural domain of the HIV-1 transmembrane glycoprotein
Abstract
Infection with HIV-1 is initiated by fusion of cellular and viral membranes. The gp41 subunit of the HIV-1 envelope plays a major role in this process, but the structure of gp41 is unknown. We have identified a stable, proteinase-resistant structure comprising two peptides, N-51 and C-43, derived from a recombinant protein fragment of the gp41 ectodomain. In isolation, N-51 is predominantly aggregated and C-43 is unfolded. When mixed, however, these peptides associate to form a stable, alpha-helical, discrete trimer of heterodimers. Proteolysis experiments indicate that the relative orientation of the N-51 and C-43 helices in the complex is antiparallel. We propose that N-51 forms an interior, parallel, homotrimeric, coiled-coil core, against which three C-43 helices pack in an antiparallel fashion. We suggest that this alpha-helical, trimeric complex is the core of the fusion-competent state of the HIV-1 envelope.
Similar articles
-
Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: conserved helical interactions underlie the broad inhibitory activity of gp41 peptides.Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9134-9. doi: 10.1073/pnas.95.16.9134. Proc Natl Acad Sci U S A. 1998. PMID: 9689046 Free PMC article.
-
A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein.Biochemistry. 1995 Nov 21;34(46):14955-62. doi: 10.1021/bi00046a001. Biochemistry. 1995. PMID: 7578108
-
Core structure of gp41 from the HIV envelope glycoprotein.Cell. 1997 Apr 18;89(2):263-73. doi: 10.1016/s0092-8674(00)80205-6. Cell. 1997. PMID: 9108481
-
A trimeric structural subdomain of the HIV-1 transmembrane glycoprotein.J Biomol Struct Dyn. 1997 Dec;15(3):465-71. doi: 10.1080/07391102.1997.10508958. J Biomol Struct Dyn. 1997. PMID: 9439994
-
Viral surface glycoproteins, gp120 and gp41, as potential drug targets against HIV-1: brief overview one quarter of a century past the approval of zidovudine, the first anti-retroviral drug.Eur J Med Chem. 2011 Apr;46(4):979-92. doi: 10.1016/j.ejmech.2011.01.046. Epub 2011 Feb 3. Eur J Med Chem. 2011. PMID: 21345545 Review.
Cited by
-
Computer-Aided Approaches for Targeting HIVgp41.Biology (Basel). 2012 Aug 20;1(2):311-38. doi: 10.3390/biology1020311. Biology (Basel). 2012. PMID: 23730525 Free PMC article.
-
Immunogenicity of HIV-1-Based Virus-Like Particles with Increased Incorporation and Stability of Membrane-Bound Env.Vaccines (Basel). 2021 Mar 10;9(3):239. doi: 10.3390/vaccines9030239. Vaccines (Basel). 2021. PMID: 33801906 Free PMC article.
-
Proteolytic processing of the human immunodeficiency virus envelope glycoprotein precursor decreases conformational flexibility.J Virol. 2013 Feb;87(3):1884-9. doi: 10.1128/JVI.02765-12. Epub 2012 Nov 21. J Virol. 2013. PMID: 23175369 Free PMC article.
-
LearnCoil-VMF: computational evidence for coiled-coil-like motifs in many viral membrane-fusion proteins.J Mol Biol. 1999 Jul 30;290(5):1031-41. doi: 10.1006/jmbi.1999.2796. J Mol Biol. 1999. PMID: 10438601 Free PMC article.
-
HIV-1 envelope proteins complete their folding into six-helix bundles immediately after fusion pore formation.Mol Biol Cell. 2003 Mar;14(3):926-38. doi: 10.1091/mbc.e02-09-0573. Mol Biol Cell. 2003. PMID: 12631714 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources